Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 35.80% is 84% above its 5-year average of 19.47%, near the high end of its 5-year range (2.77%–37.14%).
As of the fiscal period ended Tuesday, June 30, 2026. 118.25% above its 12-month average of 16.40%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 35.80%.
DEBT TO ASSETS RATIO
35.80%
DEBT TO ASSETS RATIO AVG TTM
16.40%
DEBT TO ASSETS RATIO AVG 3Y
14.80%
DEBT TO ASSETS RATIO AVG 5Y
19.47%
DEBT TO ASSETS RATIO AVG 10Y
18.55%
DEBT TO ASSETS RATIO AVG 15Y
20.25%
DEBT TO ASSETS RATIO AVG 20Y
20.16%
CURRENT VS TTM AVG
+118.25%
CURRENT VS 3Y AVG
+141.81%
CURRENT VS 5Y AVG
+83.82%
CURRENT VS 10Y AVG
+93.00%
CURRENT VS 15Y AVG
+76.76%
CURRENT VS 20Y AVG
+77.60%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 866 covered companies
CURRENT VS SECTOR MEDIAN
+39673.36%
vs the sector median at left
Alkermes plc
Market Cap
$7.00B
Debt to Assets Ratio
35.80%
TTM Avg
16.40%
3Y Avg
14.80%
5Y Avg
19.47%
Market Cap
$7.33B
Debt to Assets Ratio
0.81%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.53B
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.51B
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.49B
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alkermes plc (ALKS) | $7.00B | 35.80% | 16.40% | 14.80% | 19.47% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.33B | 0.81% | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.66B | 0.21% | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.53B | 0.43% | N/A | N/A | N/A |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 0.26% | N/A | N/A | N/A |
| Immunovant, Inc. (IMVT)vs › | $6.50B | 0.00% | N/A | N/A | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.49B | 0.74% | N/A | N/A | N/A |
| Hinge Health, Inc. (HNGE)vs › | $7.57B | 0.01% | N/A | N/A | N/A |
| HealthEquity, Inc. (HQY)vs › | $7.60B | 0.30% | N/A | N/A | N/A |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | 0.66% | N/A | N/A | N/A |
Debt/Assets
35.8%
Debt/Equity
0.87
Current Ratio
2.30
Interest Coverage
20.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 35.80% |
| 2026-03-31 | 37.14% |
| 2025-12-31 | 2.77% |
| 2025-09-30 | 3.07% |
| 2025-06-30 | 3.23% |
| 2025-03-31 | 3.56% |
| 2024-12-31 | 3.67% |
| 2024-09-30 | 16.98% |
| 2024-06-30 | 16.68% |
| 2024-03-31 | 17.43% |
| 2023-12-31 | 17.42% |
| 2023-09-30 | 16.89% |
| 2023-06-30 | 17.81% |
| 2023-03-31 | 20.49% |
| 2022-12-31 | 19.32% |
| 2022-09-30 | 21.69% |
| 2022-06-30 | 21.78% |
| 2022-03-31 | 21.82% |
| 2021-12-31 | 20.56% |
| 2021-09-30 | 21.04% |
| 2021-06-30 | 22.73% |
| 2021-03-31 | 23.69% |
| 2020-12-31 | 21.04% |
| 2020-09-30 | 21.26% |
| 2020-06-30 | 22.53% |
| 2020-03-31 | 22.50% |
| 2019-12-31 | 16.12% |
| 2019-09-30 | 17.16% |
| 2019-06-30 | 17.38% |
| 2019-03-31 | 15.87% |
| 2018-12-31 | 15.30% |
| 2018-09-30 | 15.89% |
| 2018-06-30 | 16.01% |
| 2018-03-31 | 16.18% |
| 2017-12-31 | 15.66% |
| 2017-09-30 | 16.13% |
| 2017-06-30 | 16.32% |
| 2017-03-31 | 16.37% |
| 2016-12-31 | 16.43% |
| 2016-09-30 | 16.73% |
| 2016-06-30 | 19.44% |
| 2016-03-31 | 19.42% |
| 2015-12-31 | 18.86% |
| 2015-09-30 | 18.78% |
| 2015-06-30 | 18.53% |
| 2015-03-31 | 18.52% |
| 2014-12-31 | 18.63% |
| 2014-09-30 | 19.56% |
| 2014-06-30 | 19.44% |
| 2014-03-31 | 19.76% |
| 2013-12-31 | 23.11% |
| 2013-09-30 | 24.19% |
| 2013-06-30 | 24.86% |
| 2013-03-31 | 25.10% |
| 2012-12-31 | 26.14% |
| 2012-09-30 | 27.04% |
| 2012-06-30 | 30.73% |
| 2012-03-31 | 30.97% |
| 2011-12-31 | 29.54% |
| 2011-09-30 | 29.53% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 9.10% |
| 2010-03-31 | 9.90% |
| 2009-12-31 | 11.02% |
| 2009-09-30 | 12.05% |
| 2009-06-30 | 13.03% |
| 2009-03-31 | 13.40% |
| 2008-12-31 | 15.49% |
| 2008-09-30 | 15.19% |
| 2008-06-30 | 22.70% |
| 2008-03-31 | 24.44% |
| 2007-12-31 | 21.91% |
| 2007-09-30 | 27.85% |
| 2007-06-30 | 28.18% |
| 2007-03-31 | 27.87% |
| 2006-12-31 | 28.15% |
| 2006-09-30 | 29.05% |
| 2006-06-30 | 28.25% |
| 2006-03-31 | 58.98% |
| 2005-12-31 | 62.97% |
| 2005-09-30 | 57.08% |
| 2005-06-30 | 57.08% |
| 2005-03-31 | 82.00% |
| 2004-12-31 | 64.01% |
| 2004-09-30 | 58.32% |
| 2004-06-30 | 53.55% |
| 2004-03-31 | 47.15% |
| 2003-12-31 | 41.29% |
| 2003-09-30 | 38.98% |
| 2003-06-30 | 76.72% |
| 2003-03-31 | 68.20% |
| 2002-12-31 | 60.12% |
| 2002-09-30 | 4.35% |
